Drug Shortage Report for PRIVA-GABAPENTIN

Last updated on 2018-11-29 History
Report ID 57139
Drug Identification Number 02450100
Brand name PRIVA-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name PHARMAPAR INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-07-31
Actual start date 2018-07-31
Estimated end date 2018-11-23
Actual end date 2018-11-28
Shortage status Resolved
Updated date 2018-11-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1565 BOUL LIONEL-BOULET
VARENNES, QUEBEC
CANADA J3X 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-31 English Compare
v2 2018-07-31 French Compare
v3 2018-08-01 English Compare
v4 2018-10-17 English Compare
v5 2018-10-17 French Compare
v6 2018-11-28 English Compare
v7 2018-11-28 French Compare
v8 2018-11-29 English Compare

Showing 1 to 8 of 8